October 19, 2020
Business News

Endpoint Health and Vanderbilt University Medical Center to Create World’s First Precision Medicine Trial Network Focused on Critical Illness


PALO ALTO, Calif.–()–Endpoint Health, the first targeted therapeutics company focused on integrated solutions for critical illnesses, today announced a new strategic partnership with Vanderbilt University Medical Center (VUMC) to create the first precision medicine clinical trial network focused on late-stage clinical trials in critical illness. The network will combine leading critical illness researchers, trialists and premier medical centers from across the country to create a sustained system for conducting phase II and III interventional trials intended to validate precision medicine technologies, therapies, and deployable patient-centric care approaches. It will prioritize trials investigating promising…



Click here to view the original article.

Related Posts

You might also like ...

Carter’s, Inc. to Report Third Quarter Fiscal 2020 Results on Friday, October 23, 2020
Prevailion viene nominata “Cool Vendor” (“Rivenditore in gamba”) nella relazione del 2020 a cura di Gartner nel settore Operazioni di sicurezza e intelligence sulle minacce
Columbus McKinnon Declares Quarterly Dividend of $0.06 per Share